Biomaterial Database

[Insulin tolerance test. A useful test to determine insulin resistance in obese hyperandrogenic women]. 1996

T Sin, and T Castillo, and S Muñoz, and M Candia, and G López, and M Calvillán

Unidad de Endocrinología, Facultad de Medicina, Universidad de Chile, Hospital San Juan de Dios.

BACKGROUND Insulin tolerance test is a simple method to measure insulin resistance that has a good correlation with glucose clamp studies. OBJECTIVE To use the insulin tolerance test to detect differences in insulin sensitivity between healthy and obese hyperandrogenic women and to correlate its results with those of the minimal model intravenous glucose tolerance test. METHODS Five healthy women aged 27 +/- 7 years old with a body mass index of 21 +/- 2 kg/m2 and six hyperandrogenic women aged 25 +/- 4 years old with a body mass index of 40 +/- 5 kg/m2 were studied after a 10 hours fast. For the insulin tolerance test 0.1 U/kg of crystalline insulin were injected intravenously and blood samples were drawn to measure glucose at -5,0,3,5,10 and 15 min. after the injection. Insulin resistance was calculated using the slope of descending blood glucose levels (SI1). For the intravenous glucose tolerance test, 29 blood glucose samples were obtained after an intravenous injection of 0.3 g glucose/kg followed by an injection of 0.02 U/kg of crystalline insulin. Insulin sensitivity (SI2) was calculated using Bergman's minimal model. RESULTS Healthy women had a SI1 of 0.58 (range 0.53-0.63) and a SI2 of 7.9 x 10(-4) x min-1/microU/ml (range 4.15-9.11). For hyperandrogenic women were 0.18 (range 0.06-0.29) and 0.9 x 10(-4) x min-1/microU/ml (range 0.46-1.79), respectively. Both methods had a positive correlation coefficient of 0.859 (p < 0.001). CONCLUSIONS Insulin tolerance test is a good method to measure insulin resistance and has a good correlation with the frequently sampled intravenous glucose tolerance test.

UI	MeSH Term	Description	Entries
D007333	Insulin Resistance	Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.	Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D009765	Obesity	A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260	Female		Females
D005951	Glucose Tolerance Test	A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).	Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D015309	Glucose Clamp Technique	Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration.	Euglycemic Clamping,Glucose Clamping,Euglycaemic Clamp,Euglycaemic Clamping,Euglycemic Clamp,Glucose Clamp,Glucose Clamp Technic,Clamp, Euglycaemic,Clamp, Euglycemic,Clamp, Glucose,Clamping, Euglycaemic,Clamping, Euglycemic,Clamping, Glucose,Clamps, Euglycaemic,Clamps, Euglycemic,Clamps, Glucose,Euglycaemic Clamps,Euglycemic Clamps,Glucose Clamp Technics,Glucose Clamp Techniques,Glucose Clamps,Technic, Glucose Clamp,Technics, Glucose Clamp,Technique, Glucose Clamp,Techniques, Glucose Clamp
D017588	Hyperandrogenism	A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.